Background High-flow nasal cannula (HFNC) has become a frequently used noninvasive
form of respiratory support in acute settings; however, evidence supporting its use has only …

Acute respiratory failure secondary to COVID-19 pneumonia may require a variety of non-
pharmacological strategies in addition to oxygen therapy to avoid endotracheal intubation …

Importance Helmet noninvasive ventilation has been used in patients with COVID-19 with
the premise that helmet interface is more effective than mask interface in delivering …

Introduction In COVID-19 associated hypoxemic acute respiratory failure (ARF) without
mandatory indication for urgent endotracheal intubation, a trial of CPAP may be considered …

Introduction Up to fifteen percent of patients with novel pandemic coronavirus disease
(Covid-19) have acute respiratory failure (ARF). Ratio between arterial partial pressure of …

Accumulated evidence supports the efficacy of noninvasive respiratory support therapies in
coronavirus disease 2019 (COVID-19)-related acute hypoxaemic respiratory failure …

Introduction Respiratory high dependency units (RHDUs) set up in European countries in
the last decade are based on being a transitional step between the intensive care units …

Noninvasive ventilation (NIV) has been increasingly used for the management of different
etiologies of acute hypercapnic respiratory failure (AHRF). Although NIV implementation has …

Purpose The use of noninvasive respiratory support–namely high flow of oxygen delivered
via nasal cannula (HFNC), continuous positive airway pressure (CPAP), and noninvasive …

But the question did not stop at critical care. In a randomised controlled trial, Nay et al.
recruited 265 patients on inpatient wards in 15 hospitals. Patients were randomised to …